131 related articles for article (PubMed ID: 3575560)
1. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO
Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560
[TBL] [Abstract][Full Text] [Related]
2. Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures.
Rothschild AJ; Schatzberg AF; Langlais PJ; Lerbinger JE; Miller MM; Cole JO
Psychiatry Res; 1987 Feb; 20(2):143-53. PubMed ID: 2883694
[TBL] [Abstract][Full Text] [Related]
3. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
Maj M; Ariano MG; Arena F; Kemali D
Neuropsychobiology; 1984; 11(3):168-73. PubMed ID: 6089030
[TBL] [Abstract][Full Text] [Related]
4. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
[TBL] [Abstract][Full Text] [Related]
5. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
Meltzer HY; Lowy MT; Locascio JJ
Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
[TBL] [Abstract][Full Text] [Related]
6. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
[TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ
Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
[No Abstract] [Full Text] [Related]
8. Effects of glucocorticoids on plasma catecholamines in depression.
Rupprecht R; Rupprecht M; Rupprecht C; Sofic E; Barocka A; Beck G; Noder M; Riederer P
Psychiatry Res; 1989 Aug; 29(2):187-98. PubMed ID: 2798597
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN; Sharma RP; Janicak PG; Davis JM
Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
[TBL] [Abstract][Full Text] [Related]
10. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
Wahlund B; Sääf J; Wetterberg L
Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
[TBL] [Abstract][Full Text] [Related]
11. [Effects of sodium oxybutyrate on the level of catecholamines and serotonin and monoamine oxidase activity in patients with alcoholism].
Treskov VG; Krashkina II; Tsirenina ML; Koltovaia NA; Nikol'skaia GV; Baturin AK; Gapparov MM; Mel'nik EI; Maĭskiĭ AI
Biull Eksp Biol Med; 1989 Jul; 108(7):62-4. PubMed ID: 2804304
[TBL] [Abstract][Full Text] [Related]
12. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
Loosen PT; Marciniak R
Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone increases plasma free dopamine in man.
Rothschild AJ; Langlais PJ; Schatzberg AF; Walsh FX; Cole JO; Bird ED
J Psychiatr Res; 1984; 18(3):217-23. PubMed ID: 6492009
[TBL] [Abstract][Full Text] [Related]
14. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
[TBL] [Abstract][Full Text] [Related]
15. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
[TBL] [Abstract][Full Text] [Related]
16. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.
Ravindran AV; Bialik RJ; Lapierre YD
J Affect Disord; 1994 Jun; 31(2):111-7. PubMed ID: 8071473
[TBL] [Abstract][Full Text] [Related]
17. Relationship of platelet MAO activity to characteristics of major depressive illness.
Georgotas A; McCue RE; Friedman E; Hapworth WE; Kim OM; Cooper TB; Chang I; Stokes PE
Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323
[TBL] [Abstract][Full Text] [Related]
18. High levels of plasma catecholamines in dexamethasone-resistant depressed patients.
Barnes RF; Veith RC; Borson S; Verhey J; Raskind MA; Halter JB
Am J Psychiatry; 1983 Dec; 140(12):1623-5. PubMed ID: 6650697
[TBL] [Abstract][Full Text] [Related]
19. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases.
Goldstein DS; Castillo G; Sullivan P; Sharabi Y
J Pharmacol Exp Ther; 2021 Nov; 379(3):253-259. PubMed ID: 34503991
[TBL] [Abstract][Full Text] [Related]
20. Platelet monoamine oxidase activity in patients with panic disorder.
Gorman J; Liebowitz MR; Fyer AJ; Levitt M; Baron M; Davies S; Klein DF
Biol Psychiatry; 1985 Aug; 20(8):852-7. PubMed ID: 4027301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
